Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Liver Disease Diagnostics Market?

The market size for liver disease diagnostics has seen significant growth over recent years. An increase from $36.26 billion in 2024 to $38.95 billion in 2025 is projected with a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this growth trend during the historic period include the increasing incidence of both acute and chronic liver diseases, heightened alcohol consumption, the growing awareness around liver health, and the development of the healthcare infrastructure.

The market for diagnosing liver diseases is anticipated to exhibit significant expansion in the coming years, swelling to a value of $51.62 billion in 2029 courtesy of a compound annual growth rate (CAGR) of 7.3%. The expected growth over the forecast period is thought to be due to proliferating numbers of the elderly populace, amplified spending on research & development, increased volume of biopsy procedures and illnesses, and the widening adaptation of telemedicine. Key trends forecasted for this period encompass the emergence of individually tailored medicine, enhancements in diagnostic kit technology, strides in quick testing methods, technological progression within the healthcare field, and advancements made in diagnostic techniques.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

What Drivers Are Accelerating Expansion Of The Liver Disease Diagnostics Market?

The liver disease diagnostics market is anticipated to expand due to the surge in alcohol intake. This rise in alcohol usage is influenced by changes in social norms, increased accessibility and affordability, and escalating stress or mental health issues. Diagnostics for liver diseases play a pivotal role in assessing the effects of alcohol on liver health, and important in recognizing early symptoms of liver impairment such as fatty liver, hepatitis, or cirrhosis. For example, data from the England-based government department, the National Health Service, revealed in December 2022 that the proportion of people who drank alcohol in the preceding 12 months increased with age, beginning at 62% in the 16 to 24 age bracket, and peaking at 85% for people aged 55 to 74. As such, the growth of the liver disease diagnostics market is facilitated by the escalating consumption of alcohol.

What Are The Primary Segmentation Parameters In The Liver Disease Diagnostics Market?

The liver disease diagnosticsmarket covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests; Imaging; Endoscopy; Biopsy; Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease; Non-Alcoholic Steatohepatitis; Fibrosis; Cirrhosis; Hepatocellular Carcinoma; Other Diseases

3) By End Users: Hospitals; Laboratories; Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel); Enzyme Tests (ALT, AST, ALP); Genetic Testing; Serological Tests

2) By Imaging: Ultrasound Imaging; CT Scans; MRI; Elastography (FibroScan)

3) By Endoscopy: Esophagogastroduodenoscopy (EGD); Capsule Endoscopy

4) By Biopsy: Liver Biopsy (Needle Biopsy); Fine Needle Aspiration Biopsy; Laparoscopic Biopsy

5) By Other Diagnosis Techniques: Molecular Imaging; Biomarker Testing; Fibrosis Scoring Systems

How Are Industry Trends Steering The Expansion Of The Liver Disease Diagnostics Market?

Leading businesses in the liver disease diagnostics market are shifting their focus towards the creation of innovative solutions, including non-invasive equipment for liver evaluation, with the aim of inventing more precise and effective ways of diagnosis. The term non-invasive equipment for liver evaluation refers to diagnostic methodologies that assess liver states using methods such as elastography or blood examinations, eliminating the requirement for invasive techniques like biopsies. For example, City Imaging & Clinical, a diagnostic centre based in India, introduced FibroScan in September 2024. This is a non-invasive tool for liver evaluation, designed to identify liver conditions like non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) early. This cutting-edge technology enables quick and precise measurements of liver rigidity and fat content without resorting to invasive techniques like biopsies. The process is fast, usually ranging between 5 to 15 minutes, and involves positioning a probe on the skin covering the liver. This probe releases sound waves that gauge the stiffness of the liver tissue, thus aiding in evaluating fibrosis or scarring.

Which Players Are Shaping The Competitive Landscape Of The Liver Disease Diagnostics Market?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Echosens SA, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG, bioMérieux SA, Genentech Inc., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., Enterome SA, Atlentis Therapeutics AG, 89bio Inc., Aligos Therapeutics Inc., BioPredictive SAS, Cosara Diagnostics Pvt. Ltd., Hepion Pharmaceuticals Inc., HEPQuant LLC, Aiforia Technologies Plc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

What Are The Emerging Regional Trends Driving The Liver Disease Diagnostics Market?

North America was the largest region in the liver disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp

Browse Through More Reports Similar to the Global Liver Disease Diagnostics Market 2025, By The Business Research Company

Liver Diseases Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Human Liver Model Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model